Related Experiment Video
Updated: Feb 12, 2026

Dietary Supplementation of Polyunsaturated Fatty Acids in Caenorhabditis elegans
Published on: November 29, 2013
Effect of omega-3 fatty acids supplementation during pregnancy on lung function in preschoolers: a clinical trial
R I Gutiérrez-Delgado1, A Barraza-Villarreal1, C Escamilla-Núñez1
1a Instituto Nacional de Salud Pública (INSP) , Centro de Investigaciones en Salud Poblacional, Cuernavaca , Morelos , Mexico.
Insights
Prenatal docosahexaenoic acid (DHA) supplementation did not improve lung function in Mexican preschoolers. Follow-up to 60 months showed no significant differences in respiratory system resistance or reactance between groups.
Area of Science:
- Pediatric Pulmonology
- Nutritional Science
- Prenatal Health
Background:
- Prenatal omega-3 fatty acids are known to enhance alveolar development and reduce inflammation.
- However, the long-term impact of these benefits on postnatal lung function remains unclear.
- Docosahexaenoic acid (DHA) is a key omega-3 fatty acid crucial for fetal development.
Purpose of the Study:
- To evaluate the effect of maternal docosahexaenoic acid (DHA) supplementation during pregnancy on the lung function of offspring.
- To assess lung function trajectories through 60 months of age.
Main Methods:
- A cohort of 772 Mexican preschoolers whose mothers received DHA or placebo from mid-gestation was studied.
- Lung function was assessed using forced oscillation techniques at 36, 48, and 60 months.
- Longitudinal mixed-effects models analyzed the impact of DHA on respiratory system resistance and reactance.
Main Results:
- No significant differences in respiratory system resistance or reactance were observed between the DHA and placebo groups.
- Maternal DHA supplementation did not alter the average lung function measurements.
- The trajectories of lung function development through 60 months were unaffected by prenatal DHA exposure.
Conclusions:
- Prenatal supplementation with docosahexaenoic acid (DHA) does not lead to improved pulmonary function in Mexican preschoolers.
- The study did not find evidence that maternal DHA intake influences offspring lung development or function up to five years of age.
Rationale:
Prenatal omega-3 fatty acids improve alveolarization, diminish inflammation, and improve pulmonary growth, but it is unclear whether these outcomes translate into improved postnatal lung function.
Objective:
We assessed the effect of prenatal supplementation with docosahexaenoic acid (DHA) on offspring lung function through 60 months of age.
Methods:
We included a cohort of 772 Mexican preschoolers whose mothers participated in a clinical trial (NCT00646360) of supplementation with DHA or a placebo from week 18-22 of gestation through delivery.
Measurements:
The children were followed after birth and anthropometric measurements and forced oscillation tests were performed at 36, 48, and 60 months of age. The effect of DHA was tested using a longitudinal mixed effect models.
Results:
Overall, mean (Standard Deviation) of the measurements of respiratory system resistance and respiratory system reactance at 6, 8, and 10 Hz during follow up period were 11.3 (2.4), 11.1 (2.4), 10.3 (2.2) and -5.2 (1.6), -4.8 (1.7), -4.6 (1.6), respectively. There were no significant differences in pulmonary function by treatment group. DHA did not affect the average lung function or the trajectories through 60 months.
Conclusions:
Prenatal DHA supplementation did not influence pulmonary function in this cohort of Mexican preschoolers.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Statistical Software for Data Analysis and Clinical Trials
Lung Capacity
Structure of Lipids

